Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Unusual activity? These 5 tokens have trading volumes up to 150% of their market cap

Unusual activity? These 5 tokens have trading volumes up to 150% of their market cap

CryptonewslandCryptonewsland2025/06/30 01:32
By:by Irene Kimsy
  • Trading volumes over market cap often indicate speculative or bot-driven activity.
  • Lack of updates across tokens raises transparency concerns.
  • These movements could trigger further market or regulatory reviews.

Five crypto tokens—Notcoin, Skate, MEV, ZKJ, and STMX—have drawn analyst attention after logging trading volumes that surpassed 150% of their market cap. Such high turnover in a short period is uncommon and may suggest speculative trades, automation, or even possible manipulation. Analysts are urging closer examination as regulatory eyes tighten across crypto markets.

Notcoin: Exceptional Volumes Without Clear Catalyst

Market cap:$174.34M

Current value: $0.001754

Notcoin posted a remarkable surge in daily volume, yet developers have not announced any updates. Analysts noted sharp movements between wallets, possibly linked to coordinated bot trading. Its lack of news raises doubts about whether the activity reflects genuine interest or engineered hype.

Skate: Unmatched Activity Signals Possible Wash Trades

Market cap:$6.15M

Current value:$0.04101

Skate recorded an outstanding trading turnover without any major ecosystem change. Blockchain analysts detected repetitive wallet behaviors, often associated with wash trading. The token’s low visibility and abnormal volume ratio have led some to question the validity of the price movement.

MEV: Groundbreaking Spike Tied to Arbitrage?

Market cap:$13.92M

Current value: $0.008086

MEV saw an explosive rise in exchange volume. While commonly used in Ethereum-based strategies, no protocol upgrade occurred. Analysts suggest front-running bots or arbitrage actions could be behind the spike, which lacked network or usage growth.

ZKJ: Phenomenal Surge for a Privacy Token
Market cap:$62.9M

Current value: $0.2142

ZKJ, a lesser-known privacy coin, experienced a dynamic trading boom. With no update from its team, experts suspect high-frequency wallets are circulating the token, possibly to trigger algorithmic interest or exploit thin liquidity.

STMX: Surprising Return to High-Tier Volume

Market cap:$16.28M

Current value: $0.001319

STMX posted stellar exchange volumes after a long, quiet period. Despite no new announcements, analysts believe internal redistributions or automated trading could explain the unusual movement across platforms.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market